OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 48 citing articles:

Rifampicin and its derivatives: stability, disposition, and affinity towards pregnane X receptor employing 2D and 3D primary human hepatocytes
Tomáš Smutný, Lucie Smutná, Lukáš Lochman, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116500-116500
Open Access | Times Cited: 2

Mechanisms Involved in Microglial-Interceded Alzheimer’s Disease and Nanocarrier-Based Treatment Approaches
Shadab Md, Nabil A. Alhakamy, Mohamed A. Alfaleh, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 11, pp. 1116-1116
Open Access | Times Cited: 14

The Role of Pathogens and Anti-Infective Agents in Parkinson’s Disease, from Etiology to Therapeutic Implications
Si Shen, Chan Zhang, Yuming Xu, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 27-44
Open Access | Times Cited: 11

Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound
Rodrigo Hernán Tomas‐Grau, Florencia González‐Lizárraga, Diego Ploper, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2759-2759
Open Access | Times Cited: 8

Neurodegeneration, Mitochondria, and Antibiotics
Juan M. Suárez-Rivero, Juan López‐Pérez, Inés Muela‐Zarzuela, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 416-416
Open Access | Times Cited: 4

Pharmaceutical Development of Nanostructured Vesicular Hydrogel Formulations of Rifampicin for Wound Healing
Chantal M. Wallenwein, Verena Weigel, Götz Hofhaus, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16207-16207
Open Access | Times Cited: 7

Oligomeropathies, inflammation and prion protein binding
Gianluigi Forloni, Pietro La Vitola, Claudia Balducci
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 6

Rifampicin quinone pretreatment improves neuronal survival by modulating microglia inflammation induced by α-synuclein
Leonardo Acuña, NataliaS Corbalán, Rita Raisman‐Vozari
Neural Regeneration Research (2020) Vol. 15, Iss. 8, pp. 1473-1473
Open Access | Times Cited: 8

Performance and photoresponse characterizations of pyrimidine quinolone carboxylate derivatives films-based heterojunction devices
A.A.M. Farag, Nadia A. A. Elkanzi, A. Ammar, et al.
Optik (2021) Vol. 231, pp. 166426-166426
Closed Access | Times Cited: 6

Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound
Rodrigo Hernán Tomas‐Grau, Florencia González‐Lizárraga, Diego Ploper, et al.
(2022)
Open Access | Times Cited: 4

Protective Effects of Rifampicin and Its Analog Rifampicin Quinone in a Mouse Model of Obesity-Induced Type 2 Diabetes
Amit Garg, Maroof Alam, Shakuntala Bai, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 2, pp. 253-269
Open Access | Times Cited: 2

Inhibitory effect of mitoquinone against the α-synuclein fibrillation and relevant neurotoxicity: possible role in inhibition of Parkinson’s disease
Gege Yu, Yonghui Wang, Jinhua Zhao
Biological Chemistry (2021) Vol. 403, Iss. 3, pp. 253-263
Closed Access | Times Cited: 4

The effect of rifampicin on expression of the toll-like receptor system genes in the forebrain cortex of rats prenatally exposed to alcohol
M.I. Airapetov, S.O. Eresko, P. D. Ignatova, et al.
Biomeditsinskaya Khimiya (2023) Vol. 69, Iss. 4, pp. 228-234
Closed Access | Times Cited: 1

Rifampicin Inhibits TLR4 and IL1β Gene Expression and Enhances SH-SY5Y Cell Viability After Prolonged Ethanol Exposure in an In Vitro Experiment
M.I. Airapetov, S.O. Eresko, Anna Rogova, et al.
Biomedical Chemistry Research and Methods (2024) Vol. 7, Iss. 1, pp. e00208-e00208
Open Access

Modern Pharmacological Treatment of Parkinson's Disease : Reviving Known Drugs and New Perspectives
Ilie Lastovetskyi, Bartłomiej Cytlau, Łukasz Marczyk, et al.
International Journal Of Pharmaceutical Research And Allied Sciences (2024) Vol. 13, Iss. 4, pp. 29-39
Closed Access

The non-antibiotic tetracycline COL-3 prevents microglial inflammatory responses by reducing glucose-mediated oxidative stress.
Maurício dos Santos Pereira, Elaine Aparecida Del Bel, Rita Raisman‐Vozari, et al.
Authorea (Authorea) (2021)
Open Access | Times Cited: 3

Doxycycline Therapeutic Approach in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
Elaine Aparecida Del Bel, Mariza Bortolanza, Glauce Crivelaro Nascimento, et al.
Springer eBooks (2022), pp. 1539-1559
Closed Access | Times Cited: 2

Doxycycline, an anti-inflammatory agent, alleviates dyskinesia induced by L-DOPA in Parkinsonian rats
Mariza Bortolanza, Glauce Crivelaro Nascimento, Rita Raisman Vozari, et al.
Authorea (Authorea) (2020)
Open Access | Times Cited: 2

The Effects of Rifampicin on Neuronal Survival
İlknur Yurtsever, Ebru Emekli‐Alturfan
Experimed (2020) Vol. 9, Iss. 3, pp. 138-142
Open Access

Doxycycline Therapeutic Approach in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
Elaine Aparecida Del Bel, Mariza Bortolanza, Glauce Crivelaro Nascimento, et al.
Springer eBooks (2021), pp. 1-21
Closed Access

Bidirectional Synthesis, Photophysical and Electrochemical Characterization of Polycyclic Quinones Using Benzocyclobutenes and Benzodicyclobutenes as Precursors
Amr M. Abdelmoniem, Ismail A. Abdelhamid, Holger Butenschön
European Journal of Organic Chemistry (2021) Vol. 2021, Iss. 46, pp. 6319-6333
Open Access

Previous Page - Page 2

Scroll to top